REPROCELL and BioBridge Global sign Memorandum of Understanding to accelerate global manufacturing services using clinical iPSCs

Community Blood Banks as Access Levers for CGT Delivery

A Novel, 3D Printed Bioreactor for Expansion of Mesenchymal Stem Cells Compared to the PBS Mini

Will Donors Return After Deferral: One Center’s Experience with Reinstatement After New FDA Guidance on Creutzfeldt-Jakob Disease

Our Experience in Using A1 Lectin for Solid Organ Transplant Triaging Between Group A1 and Non-Group A1 Donors

Implementing an Integrated Communication System Between an Apheresis Device and Our Center’s Blood Establishment Computer System

Impact of Automation in an Immunohematology Reference Laboratory

Expansion of Low Titer O Whole Blood Donor Eligibility

Analysis of the Benefit of Implementing a Helipad for Rotation and Resupply of Low Titer O Whole Blood to Prehospital Entities

12-Hour Hold in Large Volume Delayed Sampling of Platelet Products: Is it Needed?

Validation of a Human Anti-Tetanus Toxoid IgC Immunoassay for Tetanus Hyperimmune Programs

Solving Good Documentation Practice Errors

Harnessing Data for Breakthroughs: Electronic Batch Records in Cell and Gene Therapy